Search

everythinglearnresearchcommunity

for

Search:↓

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Gray hair can potentially be reversed, leading to new treatments.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Androgens increase growth factors in skin cells, which may lead to acne.

Targeted cancer therapies often cause serious skin problems that need careful management.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Planarian regeneration begins with a specific gene activation caused by injury, essential for healing and tissue regrowth.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Hedgehog signaling helps keep hair follicle stem cells the same in both young and old human skin.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.